Evolution of GAPDH as a druggable target of tumor glycolysis?

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1-4
Number of pages4
JournalExpert Opinion on Therapeutic Targets
DOIs
StateAccepted/In press - Mar 15 2018

Fingerprint

Glyceraldehyde-3-Phosphate Dehydrogenases
Antineoplastic Agents
Tumors
Glycolysis
heptelidic acid

Keywords

  • GAPDH
  • glyceraldehyde-3-phosphate dehydrogenase
  • Koningic acid
  • tumor glycolysis
  • Warburg effect

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

@article{49fe78f7038140ef932c5250083c2357,
title = "Evolution of GAPDH as a druggable target of tumor glycolysis?",
keywords = "GAPDH, glyceraldehyde-3-phosphate dehydrogenase, Koningic acid, tumor glycolysis, Warburg effect",
author = "Shanmugasundara Ganapathy",
year = "2018",
month = "3",
day = "15",
doi = "10.1080/14728222.2018.1449834",
language = "English (US)",
pages = "1--4",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Evolution of GAPDH as a druggable target of tumor glycolysis?

AU - Ganapathy, Shanmugasundara

PY - 2018/3/15

Y1 - 2018/3/15

KW - GAPDH

KW - glyceraldehyde-3-phosphate dehydrogenase

KW - Koningic acid

KW - tumor glycolysis

KW - Warburg effect

UR - http://www.scopus.com/inward/record.url?scp=85043711106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043711106&partnerID=8YFLogxK

U2 - 10.1080/14728222.2018.1449834

DO - 10.1080/14728222.2018.1449834

M3 - Article

SP - 1

EP - 4

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

ER -